Feb. 23, 2024
by Andrii Buvailo, PhD
Interview
In a recent interview with Laurence Barker, a partner at SV Health Investors and a key figure in the Dementia …
Feb. 6, 2024
by Andrii Buvailo, PhD
Interview
As we stand at the crossroads of artificial intelligence (AI) and biotech, what future awaits protein design, and how are …
Feb. 6, 2024
by Andrii Buvailo, PhD
Interview
In this episode, I dive deep into the burgeoning digital health landscape of the United Arab Emirates, a region rapidly …
Jan. 23, 2024
by Andrii Buvailo
Interview
The development of oncology drugs faces significant challenges, including a high failure rate (97%) in clinical trials, due to complex …
Jan. 11, 2024
by Andrii Buvailo
Interview
Tackling production inefficiencies, faulty products, and costly machine maintenance are just a few of the many issues that are hardly …
Oct. 29, 2023
by Andrii Buvailo
Interview
As the potential of artificial intelligence (AI) continues to unfold, how is it revolutionizing the intricate landscape of clinical trials? …
Sept. 22, 2023
by Andrii Buvailo
Interview
In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on …
Sept. 13, 2023
by Andrii Buvailo
Interview
Biotechnology is more than just an emerging scientific frontier, it also impacts global economy, competition, and societal transformation. To learn …
Sept. 3, 2023
by Andrii Buvailo
Interview
In August, AbbVie has secured European Commission (EC) approval for AQUIPTA® (atogepant) as a preventive treatment for adults experiencing four …
July 10, 2023
by Andrii Buvailo
Interview
Navigating the dynamic intersection of biology and data science, Eduardo Abeliuk, the CEO of TeselaGen Biotechnology, invites us on a …
June 15, 2023
by Andrii Buvailo
Interview
We're fortunate to speak with Dr. James Field, founder and CEO of LabGenius, a leading machine learning (ML)-driven protein engineering …
April 18, 2023
by Andrii Buvailo
Interview
With BioNTech’s recent $200 million merger with OncoC4’s cancer drug, the demand for personalised medicines to treat diseases such as cancer …